Results 11 to 20 of about 987,839 (297)

The use of hyperbaric oxygen to treat actinic rectal fistula after SpaceOAR use and radiotherapy for prostate cancer: a case report

open access: yesBMC Urology, 2020
Background In definitive radiation therapy for prostate cancer, the SpaceOAR® System, a hydrogel spacer, is widely used to decrease the irradiated dose and toxicity of rectum.
Tairo Kashihara   +20 more
doaj   +1 more source

Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

open access: yesRadiation Oncology, 2023
Background Small-cell lung cancer (SCLC) is a malignant tumor known for its poor prognosis. In addition to chemotherapy and immunotherapy irradiation plays a big role especially in inoperability.
Marie-Theres Kassik   +3 more
doaj   +1 more source

Response to “Radiation Therapeutic Gain and Asian Botanicals,” by Stephen Sagar [PDF]

open access: yes, 2010
Numerous botanical agents, many of which are used in whole medical system practices (i.e. traditional Chinese medicine, Ayurvedic medicine, etc.), have been shown to exhibit radiomodifying effects on tumors and normal tissues in-vitro and invivo studies.
Lawenda, Brian D.
core   +1 more source

Intravenous contrast media in radiation therapy planning computed tomography scans – Current practice in Ireland

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2019
Introduction: While Computerised Tomography (CT) remains the gold standard in radiation therapy (RT) planning, inferior soft tissue definition remains a challenge.
Shane Minogue   +3 more
doaj   +1 more source

An Unusual Case of Chronic Relapsing Tetanus Associated with Mandibular Osteomyelitis [PDF]

open access: yes, 2009
A 55-year-old man underwent radiation therapy due to malignant lymphoma of the neck. Eight years after the therapy he developed tetanus. It appears that the radiation therapy resulted in mandibular necrosis, and that this lesion may have been the ...
Fujimuro, Masahiro   +14 more
core   +1 more source

Radiation in medicine: Origins, risks and aspirations. [PDF]

open access: yes, 2014
The use of radiation in medicine is now pervasive and routine. From their crude beginnings 100 years ago, diagnostic radiology, nuclear medicine and radiation therapy have all evolved into advanced techniques, and are regarded as essential tools across ...
Donya, M   +4 more
core   +1 more source

Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head

open access: yesRadiation Oncology, 2020
Background The purpose of this study was to determine the potential of escalated dose radiation (EDR) robust intensity-modulated proton radiotherapy (ro-IMPT) in reducing GI toxicity risk in locally advanced unresectable pancreatic cancer (LAUPC) of the ...
Vijay P. Raturi   +15 more
doaj   +1 more source

Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach. [PDF]

open access: yes, 2018
Locally advanced pancreatic cancer (LAPC) is characterized by poor prognosis and low response durability with standard-of-care chemotherapy or chemoradiotherapy treatment.
Cao, Minsong   +6 more
core   +1 more source

Radiation-induced myeloid leukemia in murine models. [PDF]

open access: yes, 2014
The use of radiation therapy is a cornerstone of modern cancer treatment. The number of patients that undergo radiation as a part of their therapy regimen is only increasing every year, but this does not come without cost.
Davoren, Michael   +2 more
core   +2 more sources

Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer

open access: yesRadiation Oncology, 2018
Background The purpose of the present study was to evaluate retrospectively the efficacy and safety of proton beam therapy for elderly patients (≥80 years of age) with non-small cell lung cancer.
Takashi Ono   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy